Table 5.
Reviewers’ attitudes to conflict of interest (COI)
Item | Mean (SD) |
---|---|
Usefulness of COI information | |
The conflict of interest information I received was sufficient to objectively evaluate the manuscript | 4.01 (1.12) |
After reading the conflict of interest information provided by the authors, I knew what, if any, impact it should have on my evaluation of this manuscript | 3.93 (1.09) |
The typical peer reviewer would know how to change their review and recommend changes in the manuscript (if needed) based on COI information disclosure | 3.19 (0.95) |
General attitudes toward COI | |
It is reasonable to require authors of medical papers to disclose conflicts of interest | 4.78 (0.56) |
Requiring authors to disclose conflicts of interest improves the quality of academic publications | 4.34 (0.83) |
Conflicts of interest are a serious problem in medical research | 3.78 (0.97) |
Industry collaboration with academics is, on balance, a good thing | 3.49 (0.91) |
Investigators receiving financial support from commercial interests have a hard time being objective in their research | 3.38 (0.98) |
The problem of conflicts of interest is exaggerated in the US media | 2.54 (1.08) |
Policies dealing with conflicts of interest have become a kind of witch-hunt in medicine | 2.32 (1.08) |
Response scale for all items: 1=strongly disagree to 5=strongly agree. Means collapse across treatment arm because items were assessed at end of follow-up survey, after all reviewers had received COI disclosure. For first two items in table, n=2444. For all other items, n=905 (as these items assessed reviewers’ general attitudes toward COI, they were administered only first time given reviewer took follow-up survey—that is, for first review that reviewer submitted during study period).